Other Blood Groups

Subdecks (7)

Cards (213)

  • The Lewis blood group system comprises antigens Lea, Leb, and Lec.
  • Lewis Blood Group System has alleles of LE locus include Le (FUT3) and le
  • Lewis Blood Group System is ISBT No. 007 and has a symbol LE
  • The product of Le (FUT3) gene is an a-fucosyltransferase that adds fucose to soluble type 1 oligosaccharides
  • LE antigens are not synthesized by the red cells but are passively absorbed into the red cell from soluble antigens present in plasma.
  • Lewis antigen expression is affected by H, Se, and Le genes.
  • Lewis Antigen are not expressed on cord RBC's and are often diminished on the mother's RBC's during pregnancy.
  • Lewis Antigen are found on lymphocytes and platelets and on other tissues such as pancreas, stomach, intestine, skeletal muscle, renal cortex, and adrenal glands.
  • Soluble Lewis antigens are found in saliva as glycoproteins
  • The addition of single fucose molecule from the Le (FUT3) gene gives rise to the Leᵃ antigen
  • Le(a-) phenotype has no Lewis antigen expression due to mutation or deletion of FUT2 gene
  • The Se(FUT2) gene must first add fucose to type 1 chain to produce soluble H antigen.
  • The Le(FUT3) gene adds a second fucose to the type 1 H antigen to produce the Leᵇ antigen.
  • The four LE phenotypes are: Le(a+b-), Le(a-b+), Le(a-b-), and Le(a+b+).
  • Le(a+b-), Le and 2 se genes inherited.
  • Le(a+b-), Leᵃ antigen will be found in the secretions, but not soluble ABH antigen.
  • Le(a+b-) are nonsecretors
  • Le(a-b+), Le and 1 or 2 Se genes inherited
  • Le(a-b+) are secretors
  • Le(a-b+), Leᵃ and Leᵇ antigens will be found in the secretions as well as soluble ABH antigens.
  • Le(a-b-), two le genes inherited
  • Le(a-b-) can be secretors or nonsecretors based on the Se genes inherited
  • Le(a+b+) are rare type
  • Most neonates type as Le(a-b-) regardless of which Lewis genes they have inherited.
  • Lewis antigen are resistant to treatment with the enzymes ficin and papain, dithiothreitol (DTT), and glycine-acid (EDTA).
  • Reactivity of Lewis antibodies can be greatly enhanced by testing with enzyme-treated RBCs; hemolysis of enzyme-treated RBCs may be seen if serum is tested.
  • Lewis Antibodies are naturally occurring and can be produced by Le(a-b-) individuals
  • Anti-Leᵃ is usually IgM, but may also be IgG in total part
  • Anti-Leᵃ reacts best at room temperature but may react at 37C
  • Anti-Leᵃ can bind complement, therefore capable of triggering in vitro hemolysis
  • Anti-Leᵃ may be associated with hemolytic transfusion reactions
  • Anti-Leᵃ activity is enhanced by enzyme treatment
  • Anti-Leᵇ usualy IgM, and reacts best at room temperature
  • Anti-Leᵇ bind complement poorly
  • Anti-Leᵇ activity is enhanced by enzyme treatment
  • Anti-Leᵇ is not associated with HDN and rarely cause HTR.
  • Lewis Antibodies may appear transiently during pregnancy in Le(a-b-) women, but disappear after delivery
  • Lewis antigen neutralize Lewis antibodies. Because both anti-Leᵃ and anti-Leᵇ react with most cells on routine RBC panel. Lewis substance can be used to neutralize the antibodies and allow detection of any other antibodies present.
  • Leᵃ antigen has an ISBT no. LE1
  • Leᵇ antigen has an ISBT no. LE2